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In this study, the frequency of extended-spectrum b-lactamases (ESBL) and plasmid-mediated
quinolone resistance (PMQR) mechanisms were investigated in 206 clinical isolates of third-
generation cephalosporin (3GC)-resistant Enterobacteriaceae in four hospitals in the Republic of
Ireland. blaCTX-M-15 was the predominant ESBL gene. Of these 3GC resistant isolates, 54% were
also resistant to ciprofloxacin. Investigation of the PMQR mechanisms revealed that the aac(69)
Ib-cr gene predominated in fluoroquinolone-resistant (FQR) strains of Escherichia coli and
Klebsiella pneumoniae, while the qnrA gene predominated in the FQR strains of Enterobacter.
The blaCTX-M-15 gene was frequently identified with the aac(69)Ib-cr gene but was not always on
the same plasmid. The prevalence of the blaCTX-M-15 gene appeared to be hospital-dependent.
The epidemiology of both ESBL-producing and PMQR strains within the four hospitals indicated
that their prevalence is not due to the spread of these resistance genes between isolates from
different hospitals.
INTRODUCTION
Since the first description of extended-spectrum b-lacta-
mases (ESBLs) in 1983, incidences of ESBL-producing
bacterial strains have been reported increasingly worldwide
(Canto´n et al., 2008). In Europe there has been a transition
from the dominance of the blaTEM and blaSHV genes towards
a greater prevalence of blaCTX-M genes in ESBL-producing
members of the family Enterobacteriaceae (Bonnet, 2004).
These multi-drug resistance genes are frequently located
on plasmids. Associations between CTX-M-type ESBLs and
resistance to other antimicrobial agents have been identified
in surveys from many countries including Canada, Greece,
the UK and Italy. The fluoroquinolone (FQ) resistance genes
qnr and aac(69)Ib-cr have been frequently associated with
b-lactamase-mediated resistance, conferred by blaTEM,
blaSHV and blaCTX-M genes (Boyd et al., 2004; Woodford
et al., 2009). The dissemination of these ESBL genes and
plasmid-mediated quinolone resistance (PMQR) is making
it increasingly difficult to manage infections caused by
multi-drug resistant (MDR) strains of Enterobacteriaceae.
There have been relatively limited data published on MDR
Enterobacteriaceae isolates from the Republic of Ireland.
As part of the data collected for the European Antibiotic
Resistance Surveillance Network (EARS-Net, 2010), the
rates of third-generation cephalosporin (3GC) and FQ
resistance in invasive Escherichia coli isolates reported
from the ROI in 2009 were 6.5% and 21.7%, respectively,
while the rates of 3GC and FQ resistance in Klebsiella
pneumoniae isolates were 11.1% and 10.8%, respectively.
The proportions of 3GC-resistant E. coli and K. pneumo-
niae in which ESBL production was also detected were
85.5% and 78.1%, respectively. The aims of the present
study were to identify the mechanisms of plasmid-
mediated resistance to 3GCs and FQs in MDR Enterobac-
teriaceae isolates collected from four Irish hospitals,
characterize the plasmids harbouring the aac(69)Ib-cr gene,
and investigate the ability of these plasmids to enhance the
development of ciprofloxacin resistance in Escherichia coli.
METHODS
Bacterial strains. Clinical isolates of E. coli, K. pneumoniae and
Enterobacter were collected from a 900-bed tertiary referral university
hospital in the Republic of Ireland between July 2006 and June 2008
(CLSI, 2007). The bacteria, which were collected from all sites of
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Wa¨denswil (ACW), Postfach, 8820 Wa¨denswil, Switzerland.
Abbreviations: 3GC, third-generation cephalosporin; ESBL, extended-
spectrum b-lactamase; FQ, fluoroquinolone; FQR, fluoroquinolone-
resistant; MDR, multi-drug resistant; PMQR, plasmid-mediated quinolone
resistance.
The GenBank/EMBL/DDBJ accession number for the aac(69)Ib-cr
partial gene sequence of Enterobacter aerogenes is EU081298.1.
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infection by the diagnostic microbiology laboratory, were screened
for resistance to 3GCs cefotaxime and/or ceftazidime using in vitro
antibiotic susceptibility testing according to CLSI guidelines, except
for isolates of E. coli collected from urinary samples, which were not
screened for 3GC resistance. Additionally, 3GC- and FQ-resistant
isolates were collected from three other Irish hospitals during the
same period and added to the main collection. The total numbers of
isolates of E. coli, K. pneumoniae and Enterobacter collected were 73,
56 and 77, respectively.
PCR detection of resistance genes. All isolates were screened for
the presence of blaTEM, blaSHV, blaOXA and blaCTX-M genes by using
multiplex PCR (Colom et al., 2003; Woodford et al., 2006). PCR-
positive isolates were confirmed by individual PCRs and the purified
products were sequenced in the forward and reverse directions using
the amplification primers or the primers blaTEM forward 59-AGAT-
CAGTTGGGTGCACGAG-39and blaTEM reverse 59-CTTGGTCTGA-
CAGTTACC-39 for the blaTEM PCR positives. All isolates, regardless
of their susceptibility to FQ, were analysed for the aac(69)Ib-cr gene
by using PCR, and for qnrA, qnrB and qnrS genes by using multiplex
PCR (Robicsek et al., 2006; Gay et al., 2006). PCR-positive isolates
were confirmed by individual PCR and subsequent sequencing in the
forward and reverse directions.
Plasmid transformation and profiles. All aac(69)Ib-cr-positive
isolates were selected for plasmid analysis. Plasmid extractions were
performed using a Qiagen Plasmid Midi kit. Extracted plasmids were
transformed into TOP10 competent E. coli cells by electroporation
and the cells were spread on Mueller–Hinton agar containing
ampicillin, cefotaxime or kanamycin (20 mg l21 each). All resulting
transformant colonies were screened both for the presence of the
aac(69)Ib-cr gene and all of the additional plasmid-mediated ESBL
genes which were present in the parent clinical isolate. Plasmids were
extracted from PCR-positive transformants and E. coli NCTC 13400
(pEK499) cells using the Qiagen Plasmid Midi kit. The extracted
plasmids were digested using restriction enzyme PstI and separated
on 0.8% agarose gels at 100 V for 5 min followed by 75 V for 2 h.
The resulting banding patterns were analysed using BioNumerics
software in order to determine the percentage similarity between the
plasmids.
Mutation studies. Transformants and competent cells were
individually inoculated into LB broth and incubated at 37 uC
overnight. A 100 ml volume of each of the overnight cultures was
spread on to Mueller–Hinton agar plates containing ciprofloxacin at
concentrations equal to the MIC or 26 MIC for that strain (Walsh
et al., 2003). Plates with each drug concentration, together with a
control with no antibiotic, were inoculated in triplicate and incu-
bated at 37 uC for 48 h. The mutants generated were purified by
subculturing twice on plates with the selective ciprofloxacin
concentration. The MIC of ciprofloxacin for each of the mutants
was determined according to the CLSI guidelines (CLSI, 2007).
Successive generations of mutants were derived in the same way as the
first generation. This process was repeated using increasingly higher
concentrations of ciprofloxacin until high-level resistance was
achieved (MIC ¢8 mg l21) or the MICs for successive generations
remained constant over two successive generations.
RESULTS AND DISCUSSION
Antibiotic resistance profiles
The prevalence and range of multi-drug resistance in the 206
3GC-resistant isolates are shown in Table 1. The majority of
isolates were collected from hospital 4. Within the 3GC-
resistant populations from the four hospitals, 41% of the E.
coli, 45% of the K. pneumoniae and 5% of the Enterobacter
isolates were ESBL-positive. Few strains of K. pneumoniae or
E. coliwere resistant to imipenem but almost one third of the
Enterobacter isolates were imipenem resistant, all of which
were isolated from hospital 4. There were significantly
higher levels of amikacin resistance in isolates of K.
pneumoniae and E. coli when compared to another Irish
Table 1. Prevalence of MDR isolates collected from four Irish hospitals
AMC, amoxicillin+clavulanic acid; CTX, cefotaxime; CAZ, ceftazidime; TZP, piperacillin–tazobactam; CIP, ciprofloxacin; LEVO, levofloxacin, AK,
amikacin; GM, gentamicin; IMI, imipenem.
Taxon/source Resistant to
3GC
Positive for
ESBL by PCR
Resistant to:
AMC CTX CAZ TZP CIP LEVO AK GM IMI
Enterobacter 77 4 73 73 73 68 30 41 1 29 23
Hospital 1 5 0 5 5 5 1 4 3 0 0 0
Hospital 2 11 0 10 10 10 7 11 9 0 0 0
Hospital 3 3 0 3 2 2 1 3 2 0 0 0
Hospital 4 58 4 55 56 56 59 12 27 1 29 23
K. pneumoniae 56 25 51 51 49 44 39 37 8 16 7
Hospital 1 2 1 2 2 2 0 2 1 0 0 0
Hospital 2 7 3 6 7 7 3 7 6 0 0 0
Hospital 3 11 10 9 11 11 4 11 11 0 0 0
Hospital 4 36 11 34 31 29 37 19 19 8 16 7
E. coli 73 30 72 73 59 59 42 41 23 32 4
Hospital 1 3 1 2 3 2 2 3 3 0 0 0
Hospital 2 11 3 8 11 6 6 11 11 0 0 0
Hospital 3 15 13 14 15 8 8 15 14 0 0 0
Hospital 4 44 13 48 44 43 43 13 13 23 32 4
ESBL and plasmid-mediated quinolone resistance analysis
http://jmm.sgmjournals.org 143
Downloaded from www.microbiologyresearch.org by
IP:  149.157.61.209
On: Mon, 25 Jan 2016 16:39:07
collection, where only one amikacin-resistant isolate was
described among 66 MDR strains of Enterobacteriaceae
(Mac Aoga´in et al., 2010). Aminoglycoside-resistant isolates
were also only detected in hospital 4. The proportions of
ciprofloxacin- and levofloxacin-resistant strains within the
3GC-resistant populations were, respectively, 58 and 56% in
E. coli, 70 and 66% in K. pneumoniae and 39 and 53% in
species of Enterobacter. Almost all of the 3GC-resistant
isolates from hospitals 1, 2 and 3 were FQ resistant; however,
¡50% of the isolates from hospital 4 were resistant to FQs.
Third-generation cephalosporin resistance
mechanisms
In strains of E. coli and K. pneumoniae, the predominant
ESBL gene was blaCTX-M-15. This has also been reported as
the most common ESBL gene in another Irish survey of
25 MDR E. coli isolates (Mac Aoga´in et al., 2010). The
distribution of the blaCTX-M genes was hospital dependent,
as shown in Table 2. Hospital 3 contained 22 blaCTX-M-15-
positive isolates, while the isolates from hospital 4 contained
the largest variety of blaCTX-M genes, including blaCTX-M-2,
blaCTX-M-15 and blaCTX-M-25. The blaCTX-M-25 gene encodes a
rare ESBL that was first associated with an outbreak in
Canada (Munday et al., 2004). Our collection contained one
blaCTX-M-15-positive Enterobacter isolate from hospital 4.
Few blaTEM and blaSHV ESBL genes were detected. However,
Table 2. Distribution of ESBL and PMQR genes among
206 MDR Enterobacteriaceae isolates collected from 4 Irish
hospitals
Taxa: 1, E. coli; 2, K. pneumoniae; 3, Enterobacter. Values represent
number of isolates containing bla genes, conferring b-lactam
resistance, aac(69)Ib-cr or qnr genes, conferring FQ resistance, or a
mixture of these genes.
Resistance element 1 2 3
Hospital 1
blaTEM-1 1
blaTEM-170 1
blaSHV-11 1
blaOXA-1 1 1 2
blaCTX-M-2 1
aac(69)Ib-cr 1 1
qnrA 1
blaTEM-1+blaSHV-11+blaOXA
+qnrA+aac(69)Ib-cr
1
blaOXA+blaTEM-170
+blaCTX-M-2+aac(69)Ib-cr
1
Hospital 2
blaTEM-1 7 2 3
blaTEM-171 1
blaTEM-172 1
blaSHV-11 1 2
blaSHV-12 1
blaSHV-28 1
blaSHV-123 1
blaSHV-124 1
blaSHV-126 1
blaOXA-1 4 1 1
blaCTX-M-15 3
blaCTX-M-25 1
aac(69)Ib-cr 2
qnrA 1
qnrB 1 1
qnrA+qnrB 1
blaCTX-M-15+blaOXA
+aac(69)Ib-cr
1
blaTEM-1+blaSHV-11+blaOXA
+aac(69)Ib-cr
1
qnrA+blaSHV-12 1
qnrA+qnrB+blaSHV-126 1
qnrB+blaSHV-124 1
Hospital 3
blaTEM-1 8 4 1
blaTEM-40 1
blaTEM-173 1
blaOXA-1 7 7
blaCTX-M-15 13 9
aac(69)Ib-cr 7 6
qnrS 1
blaTEM-1+blaCTX-M-15+blaOXA
+aac(69)Ib-cr
4 3
blaCTX-M-15+blaOXA
+aac(69)Ib-cr
2 3
blaOXA+aac(69)Ib-cr 1
Table 2. cont.
Resistance element 1 2 3
Hospital 4
blaTEM-1 21 12 8
blaTEM-30 1
blaTEM-174 1
blaSHV-11 1
blaSHV-12 2
blaSHV-125 1
blaSHV-127 1
blaOXA-1 18 8 11
blaCTX-M-2 1 1
blaCTX-M-15 5 8 1
blaCTX-M-25 1
aac(69)Ib-cr 3 3 2
qnrA 1 7
qnrB 2
qnrS 1
blaTEM-1+blaCTX-M-15+blaOXA
+aac(69)Ib-cr
1 1
blaCTX-M-15+blaOXA
+aac(69)Ib-cr
2
blaOXA+aac(69)Ib-cr
qnrA+blaSHV-12 1 1 2
qnrA+blaTEM-1 1
qnrA+blaOXA-1 2
qnrB+blaSHV-11 1 3
qnrB+blaSHV-125+blaCTX-M-15 1
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in all three populations from each hospital, the predominant
b-lactamase genes were blaTEM-1 and blaOXA-1. Five novel
ESBL genes, blaTEM-170 to blaTEM-174, were detected in
isolates of E. coli. These were isolated from the four different
hospitals. Five novel blaSHV genes were identified: the
blaSHV-126 gene was identified in an Enterobacter isolate from
hospital 2 and the genes blaSHV-123, blaSHV-124, blaSHV-125
and blaSHV-127 were detected in K. pneumoniae isolates from
hospitals 2 and 4. Of these, only blaSHV-127 was associated
with an ESBL-positive phenotype.
PMQR genes and plasmid epidemiology analysis
It was possible to segregate the predominant PMQR gene
determinants based on bacterial species (Table 2). Isolates
of E. coli and K. pneumoniae contained predominantly
aac(69)Ib-cr genes and few qnr genes, whereas Enterobacter
isolates contained more qnr genes than aac(69)Ib-cr genes.
The distribution of resistance genes within isolates from the
four hospitals followed this general pattern; however, isolates
from hospital 3 contained almost exclusively aac(69)Ib-cr
genes. Isolates from hospital 4 contained the largest number
of qnr genes, which were more frequently detected than
aac(69)Ib-cr genes, indicating an unusual trend within this
hospital with a predominance of qnr rather than aac(69)Ib-cr
genes. One Enterobacter isolate contained both qnrA and
qnrB genes and one isolate of K. pneumoniae was positive
for both qnrA and aac(69)Ib-cr genes. To our knowledge,
this is the first report of an aac(69)Ib-cr gene identified
in Enterobacter aerogenes. All isolates that contained an
aac(69)Ib-cr gene were intermediately resistant or resistant to
ciprofloxacin; however, three qnrA-positive strains and one
qnrB-positive strain were ciprofloxacin-susceptible. The
aac(69)Ib-cr gene was always co-located with at least one
b-lactamase gene (Table 2). The most prevalent combination
of b-lactamase and aac(69)Ib-cr gene was aac(69)Ib-cr
+blaOXA-1+blaTEM-1+blaCTX-M-15, which was identified in
four and seven isolates of K. pneumoniae and E. coli,
respectively. This pattern of co-location was detected in
isolates from hospitals 2, 3 and 4 but was most pronounced
in isolates from hospital 3, with seven isolates harbouring
this genotype. These genes were also reported on the pEK499
plasmid in epidemic strains of E. coli from the UK
(Woodford et al. 2009). The second most frequently
identified association of genes was aac(69)Ib-cr+blaOXA-1
+blaCTX-M-15, which was present in four isolates of E. coli
and three isolates of K. pneumoniae. The qnrA and qnrB
genes were detected with blaSHV genes in isolates from
hospitals 2 and 4.
The transformation studies indicated that the aac(69)Ib-cr
gene was always associated with the blaOXA-1 gene and was
frequently associated with the genes blaCTX-M-15 and
blaTEM-1. The presumption, in many studies to date, has
been that these genes are co-transferred on the same
plasmid as they are often identified in the same strains;
however, in the transformation studies, in nine of the 19
strains positive for both aac(69)Ib-cr and blaCTX-M-15 genes,
the blaCTX-M-15 gene was not co-transferred with aac(69)
Ib-cr into competent E. coli cells. The nine clinical strains
Fig. 1. Comparison of banding patterns of
PstI-digested plasmids from transformants
and pEK499 from E. coli NCTC 13400 with
a dendrogram showing percentage similarity
between banding patterns. CTX-M-15 indi-
cates that this plasmid contains a blaCTX-M-15
gene.
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harbouring these plasmids comprised both K. pneumoniae
and E. coli. Digested plasmids from the transformants were
compared to each other and to the UK epidemic pEK499,
which contains both aac(69)Ib-cr and blaCTX-M-15 genes,
using BioNumerics software, as shown in Fig. 1. The only
plasmid profiles that shared 100% identity were those
where plasmids originated from two Enterobacter isolates
(transformants 4T and 5T) or from two isolates of K.
pneumoniae (transformants 25T and 26T); all four of these
plasmids were blaCTX-M-15-negative. The former of these
plasmids were the only two aac(69)Ib-cr-harbouring
plasmids identified in Enterobacter isolates in this study.
These strains had both been isolated in the same hospital
but from different patients. The banding patterns of the
remaining plasmids were diverse and did not show any
distinct patterns. No plasmids were, therefore, identical to
plasmid pEK499; however, it is possible that genetic
rearrangement has occurred, which could not have been
discerned using restriction analysis.
Generation of ciprofloxacin-resistant mutants
from isogenic E. coli transformants containing
aac(6§)Ib-cr plasmids
The cr variant of the aac(69)-Ib gene encodes an
aminoglycoside acetyltransferase that confers reduced
susceptibility to ciprofloxacin by N-acetylation of its
piperazinyl amine (Robicsek et al., 2006). The aac(69)Ib-cr
gene has been shown previously to enhance the ability of
E. coli to develop ciprofloxacin resistance. The experiments
of Robicsek et al. (2006) examined the development of
ciprofloxacin resistance when the aac(69)Ib-cr gene was
ligated into a well-characterized plasmid and transformed
into E. coli. However, in clinical isolates, the aac(69)Ib-cr
gene was not present on a plasmid in isolation and, as shown
in this and other studies, other genes and elements are
present on the same plasmid as the aac(69)Ib-cr gene.
Therefore, we sought to examine the abilities of natural
plasmids, which contained the aac(69)Ib-cr gene, to enhance
the selection of ciprofloxacin resistance.
Table 3. Results of mutation studies of transformants containing aac(69)Ib-cr-harbouring plasmids
Competent cell/
transformant parent
MIC of ciprofloxacin
(mg l”1)
Generation number
required to produce
resistant mutants
MIC of ciprofloxacin for
final generation mutants
(mg l”1)
E. coli 0.002 4 16
Hospital 1
9T 0.032 3 8
10T 0.008 5 .16
Hospital 2
11T 0.008 4 8
12T 0.004 3 8
13T 0.008 5 16
14T 0.004 4 8
Hospital 3
15T 0.008 3 8
16T 0.008 5 8
17T 0.002 5 8
18T 0.004 4 0.5
19T 0.004 7 2
20T 0.008 6 4
22T 0.002 7 2
23T 0.008 7 2
24T 0.004 5 8
25T 0.002 5 1
26T 0.002 6 1
27T 0.004 6 4
Hospital 4
1T 0.008 5 16
2T 0.004 5 0.25
3T 0.06 5 8
4T 0.016 4 .16
5T 0.032 4 8
6T 0.008 4 .16
7T 0.008 4 8
8T 0.004 5 0.5
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Highly resistant mutants were generated from 16 of the
26 transformants (Table 3). High-level ciprofloxacin-
resistant mutants (MIC ¢16 mg l21) were generated
from the E. coli competent cells in the fourth genera-
tion that lacked an aac(69)Ib-cr plasmid. None of the
transformants containing the aac(69)Ib-cr gene generated
high-level ciprofloxacin-resistant mutants in less than
four generations. High-level resistance in some mutants
was achieved in four to five generations. Resistant
mutants with MICs of 8 mg l21 were generated from
11 transformants, resistant mutants with MICs of 4
mg l21 were generated from two transformants and
intermediately resistant mutants (MIC 2 mg l21) were
generated from three transformants. Five transformants
failed to produce resistant mutants after successive
generations. There was no correlation between MICs
for the transformants and their ability to generate
ciprofloxacin-resistant mutants. However, all of the
transformants generated from isolates from hospitals 1
and 2 resulted in high-level resistant mutants with MICs
¢8 mg l21. Hospital 3 contained the highest number of
aac(69)Ib-cr-positive isolates; however, only four trans-
formants generated mutants with MICs of 8 mg l21. Six
of the eight transformants obtained from isolates from
hospital 4 generated mutants with MICs ¢8 mg l21.
This suggests a difference in the abilities of isolates from
the four hospitals to generate FQR mutants.
Conclusions
This study has identified a high distribution and presence
of PMQR and ESBL elements in isolates from each of the
hospitals. The blaCTX-M-15 and aac(69)Ib-cr genes were the
predominant ESBL and PMQR genes in these isolates as a
whole, but the qnr genes were the predominate PMQR
elements in hospital 4. There was a wide variety of
plasmids carrying similar resistance genes. The qnr
PMQR genes emerged most frequently in Enterobacter
isolates. Novel ESBL genes were detected in isolates from
each of the four hospitals and carbapenem and amino-
glycoside resistance was detected in all three bacterial
populations from one hospital. This highlights a potential
threat to the further treatment of these infections. The
epidemiological differences in the presence and co-
location of PMQR and ESBL genes between the four
hospitals suggest that while each hospital contains
PMQR- and ESBL-positive isolates, these are not the
result of a particular plasmid spreading through bacterial
populations in hospitals or between patients. The results
of the mutation studies highlight the differences between
the plasmids isolated from the four different hospitals.
This is particularly important with respect to hospital 3,
which contained the largest number of aac(69)Ib-cr-
positive isolates but resulted in the lowest number of
ciprofloxacin-resistant mutants. Thus, the presence of the
aac(69)Ib-cr gene in these isolates did not necessarily
result in ciprofloxacin resistance.
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